MedAdvisor Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDR.AX research report →
Price Chart
About the company
Operating through its subsidiaries across Australia, the United States, the United Kingdom, and Asia, MedAdvisor Limited is dedicated to creating and deploying software solutions. A core offering is the MedAdvisor platform, a comprehensive system for medication management and adherence. This platform is engineered to enhance health outcomes by leveraging technology to connect healthcare professionals with their patients, thereby improving medication compliance through targeted health programs.
- CEO
- Richard Ratliff
- IPO
- 2011
- HQ
- Camberwell, VIC, AU
Get TickerSpark's AI analysis on MDR.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $14.00M
- P/E
- -0.16
- Fwd P/E
- 7.33
- PEG
- 0.00
- P/S
- 0.31
- P/B
- 0.99
- EV/EBITDA
- -0.01
- Div Yield
- 0.00%
- Gross Margin
- -38.88%
- Op Margin
- -81.59%
- Net Margin
- -196.24%
- ROE
- -1566.68%
- ROIC
- -244.95%
Latest fiscal year · YoY change
- Revenue
- $62.99M-48.4%
- Gross Profit
- $3.97M-83.2%
- Op Income
- $-6,732,831
- Net Income
- $-60,208,977-7700.9%
- EPS
- $-0.10-7242.9%
- OCF Growth
- -376.9%
- FCF Growth
- -528.3%
- 52W High
- $0.32
- 52W Low
- $0.02
- 50D MA
- $0.03
- 200D MA
- $0.07
- Beta
- 1.03
- RSI (14)
- 39
- Avg Volume
- 1.38M
No earnings-call transcripts are available for MDR.AX yet.
- Free Float
- 61.8%
- Shares Outstanding
- 636.52M
- Float Shares
- 393.51M
Our MDR.AX coverage
Recent articles, reports, and earnings notes.
No research on MDR.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MDR.AX report →